Click here to go to the previous page
What's the Point? Can Point of Care Devices Enhance Clinical Trials?
Program Code:
424
Date:
Thursday, June 27, 2013
Time:
10:45 AM to 12:15 PM
EST
CHAIR
:
Erin Iturriaga,
RN (SCHAGY), Clinical Trials Specialist,
National Heart, Lung, and Blood Institute (NHLBI), United States
Erin currently works as a Clinical Trials Specialist at the NHLBI and brings a strong background in clinical research, including management, education, and regulatory responsibilities. Erin is a RN and has a degree in the Health Sciences from The George Washington University School of Medicine.
|
SPEAKER
(S):
Sukhwant Khanuja,
PhD (SPKNON), President and CEO,
Carematix / Blipcare Inc, United States
Dr. Khanuja has led innovations like “personalization of medication delivery” & “predictive models for re-admission”. Carematix develops user friendly RPM solutions driving “sustained compliance” in programs globally. He worked at McKinsey & Co., has a PhD (Purdue Univ.), & BTech from IIT, Kanpur.
|
Anu Rao, MD (SPKAGY), Medical Officer, Division of Cardiovascular Services, National Heart, Lung, and Blood Institute (NHLBI), United States
Description
The session will discuss how point of care (POC) devices for clinical application may enhance the clinical trial enterprise. Clinical trials serve as a venue for testing and validating emerging or existing POC devices for successful application and commercialization of these technologies.